Published on
Last updated on
NMPA Fast-Track Approvals: Applications and Approvals Passed
The NMPA (National Medical Products Administration) accepted 7 domestic and 1 overseas applications for fast-track approval and passed 2 other fast-track approvals for the following medical devices.
The “fast-track” for regulatory approval is a policy that was initiated in China from 2014. Whilst there have been no recent regulatory changes to the process, there has been an uptick in approvals as the system matures and more manufacturers seek to take advantage of the regulatory pathway.
AI software has been in the news frequently recently. Read our previous article about the developments for AI medical devices detecting diabetic retinopathy in conventional colour fundus photography.
By Jacky Li. Contact Cisema if you would like to learn more.
Connect with Cisema
With more than 20 years of experience and a team of over 100 specialists, Cisema helps global companies achieve compliance across Asia Pacific with confidence and accelerate market entry.
Stay Informed with Monthly News and Analysis
Stay informed with the latest regulatory changes, expert insights, and market opportunities across APAC, delivered straight to your inbox.
Related News
China Expands MRI Registration Requirements Under New 2026 Review Guideline
Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.
China CMDE Releases New Review Documents for Oncology NGS & HLA-B*58:01 Reagents
The new documents clarify expectations for Tier III variants, companion diagnostic clinical evaluation, tissue and plasma registration, and HLA-B*58:01 analytical validation.
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites
As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories